Data / Drug companies / Hydroxychloroquine sulfate
Hydroxychloroquine sulfate: 33 companies and 57 products in the FDA NDC directory
Hydroxychloroquine sulfate is listed in the FDA National Drug Code Directory by 33 companies, with 57 products in commercial distribution. 52 of the products (91.2%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, film coated; tablet, and the newest product started marketing on May 8, 2025.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 33
- Products
- 57
- Generic (ANDA) products
- 52 (91.2%)
- Application numbers
- 12
- Routes
- Oral
- Brand names
- Plaquenil, Sovuna
- openFDA record search
- api.fda.gov
Companies that list hydroxychloroquine sulfate
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Bryant Ranch Prepack | 8 | tablet, film coated; tablet | Generic drugs (ANDA) | May 8, 2025 |
| A-S Medication Solutions | 6 | tablet, film coated; tablet | Generic drugs (ANDA) | May 12, 2020 |
| Accord Healthcare Inc. | 4 | tablet | Generic drugs (ANDA) | September 28, 2021 |
| Aphena Pharma Solutions - Tennessee, LLC | 4 | tablet, film coated; tablet | Generic drugs (ANDA) | May 17, 2018 |
| Dr. Reddy's Laboratories Inc. | 4 | tablet, film coated | Generic drugs (ANDA) | October 24, 2022 |
| Ani Pharmaceuticals, Inc. | 2 | tablet, film coated | New drug applications (NDA) | September 15, 2023 |
| Cardinal Health 107, LLC | 2 | tablet, film coated | Generic drugs (ANDA) | May 1, 2018 |
| NuCare Pharmaceuticals,Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | October 1, 2019 |
| Advanz Pharma (US) Corp. | 1 | tablet | New drug applications (NDA) | June 28, 2013 |
| American Health Packaging | 1 | tablet, film coated | Generic drugs (ANDA) | September 3, 2008 |
| Amneal Pharmaceuticals NY LLC | 1 | tablet, film coated | Generic drugs (ANDA) | May 17, 2018 |
| Amneal Pharmaceuticals NY LLC | 1 | tablet, film coated | Generic drugs (ANDA) | May 17, 2018 |
| Aphena Pharma Solutions - Tennessee, LLC | 1 | tablet | Generic drugs (ANDA) | May 8, 2025 |
| Asclemed USA, Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | October 1, 2019 |
| Aurobindo Pharma Limited | 1 | tablet, film coated | Generic drugs (ANDA) | March 7, 2025 |
| AvPAK | 1 | tablet, film coated | Generic drugs (ANDA) | May 15, 2020 |
| Bryant Ranch Prepack | 1 | tablet | Generic drugs (ANDA) | May 8, 2025 |
| Bryant Ranch Prepack | 1 | tablet | Generic drugs (ANDA) | October 24, 2022 |
| Coupler LLC | 1 | tablet, film coated | Generic drugs (ANDA) | February 24, 2025 |
| Creekwood Pharmaceuticals LLC | 1 | tablet | Generic drugs (ANDA) | May 8, 2025 |
| Ipca Laboratories Limited | 1 | tablet, film coated | Generic drugs (ANDA) | June 3, 2024 |
| Laurus Labs Limited | 1 | tablet, film coated | Generic drugs (ANDA) | March 6, 2023 |
| Major Pharmaceuticals | 1 | tablet, film coated | Generic drugs (ANDA) | May 1, 2018 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 1 | tablet, film coated | Generic drugs (ANDA) | January 3, 2008 |
| NorthStar Rx LLC | 1 | tablet, film coated | Generic drugs (ANDA) | October 1, 2019 |
| Preferred Pharmaceuticals Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | July 1, 2020 |
| Proficient Rx LP | 1 | tablet | New drug applications (NDA) | June 28, 2013 |
| Quallent Pharmaceuticals Health LLC | 1 | tablet, film coated | Generic drugs (ANDA) | September 30, 2022 |
| Rising Pharma Holdings, Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | May 29, 2023 |
| Sun Pharmaceutical Industries, Inc. | 1 | tablet | Generic drugs (ANDA) | June 18, 2018 |
| Teva Pharmaceuticals USA, Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | October 8, 2020 |
| Zydus Lifesciences Limited | 1 | tablet, film coated | Generic drugs (ANDA) | January 3, 2008 |
| Zydus Pharmaceuticals USA Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | January 3, 2008 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 39 | 68.4% |
| Tablet | 18 | 31.6% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 52 | 91.2% |
| New drug applications (NDA) | 5 | 8.8% |
Pharmacologic classes
| Class | Products |
|---|---|
| Antimalarial | 57 |
| Antirheumatic Agent | 57 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.